Literature DB >> 19450649

Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice.

Rebecca Voltan1, Arianna Castaldello, Egidio Brocca-Cofano, Rita De Michele, Chiara Triulzi, Giuseppe Altavilla, Luisa Tondelli, Michele Laus, Katia Sparnacci, Eva Reali, Riccardo Gavioli, Barbara Ensoli, Antonella Caputo.   

Abstract

Cationic block copolymers spontaneously assemble via electrostatic interactions with DNA molecules in aqueous solution giving rise to micellar structures that protect the DNA from enzymatic degradation both in vitro and in vivo. In addition, we have previously shown that they are safe, not immunogenic and greatly increased antigen-specific CTL responses following six intramuscular inoculations of a very low dose (1microg) of the vaccine DNA as compared to naked DNA. Nevertheless, they failed to elicit detectable humoral responses against the antigen. To gain further insight in the potential application of this technology, here we show that a shorter immunization protocol based on two DNA intramuscular inoculations of 1microg of DNA delivered by these copolymers and a protein boost elicits in mice broad (both humoral and cellular) and long-lasting responses and increases the antigen-specific Th1-type T cell responses and CTLs as compared to priming with naked DNA. These results indicate that cationic block copolymers represent a promising adjuvant and delivery technology for DNA vaccination strategies aimed at combating intracellular pathogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19450649     DOI: 10.1016/j.vaccine.2009.05.031

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

Review 1.  Therapeutic HPV DNA vaccines.

Authors:  Ken Lin; Elena Roosinovich; Barbara Ma; Chien-Fu Hung; T-C Wu
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

2.  Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccines.

Authors:  Fausto Titti; Maria T Maggiorella; Flavia Ferrantelli; Leonardo Sernicola; Stefania Bellino; Barbara Collacchi; Emanuele Fanales Belasio; Sonia Moretti; Maria Rosaria Pavone Cossut; Roberto Belli; Erika Olivieri; Stefania Farcomeni; Daniela Compagnoni; Zuleika Michelini; Michela Sabbatucci; Katia Sparnacci; Luisa Tondelli; Michele Laus; Aurelio Cafaro; Antonella Caputo; Barbara Ensoli
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

3.  The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.

Authors:  Francesco Nicoli; Valentina Finessi; Mariaconcetta Sicurella; Lara Rizzotto; Eleonora Gallerani; Federica Destro; Aurelio Cafaro; Peggy Marconi; Antonella Caputo; Barbara Ensoli; Riccardo Gavioli
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.